30 closest matches · ranked by relevance
Metastatic Brain Tumors · Progression · Radiation Necrosis
Primary: Percentage of Patients With Progression-Free Survival (PFS) — 74; 74 percentage of patients
Pulp Necroses
Primary: Cell Count of Inflammatory Infiltrate Per Cross-Sectional Area at 400X Magnification — 10.3; 10.5 Cells / 0.1 mm^2
Wrinkle · Rosacea · Scarring
Primary: Global Aesthetic Improvement Scale — 0.95; 1.05 score on a scale
Body Contouring
Primary: Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs — -3.895; -1.136 inches
Hypertrichosis
Primary: Change in Hair Growth — 57.6; 52.1; 39.3; 29.9 % hair reduction — p=0.2879
Acne Vulgaris
Primary: Change From Baseline in Papule Acne Lesions at Week 10 — -4.63; -0.13 papule acne lesions — p=0.01
Scar
Primary: POSAS (The Patient and Observer Scar Assessment Scale) Measure — 2.5; 2.5; 2.5 Score
Myopia · Astigmatism
Primary: Percentage of Eyes With Uncorrected High Contrast Distance Visual Acuity of 20/40 or Better — 99.2 percentage of eyes
Autistic Disorder
Primary: Mean Change From Baseline to Study Endpoint in the Aberrant Behavior Checklist (ABC) Irritability & Agitation Subscale Score. — -8.68; -6.05 score on a scale
Erythematotelangiectatic Rosacea · Papulopustular Rosacea
Primary: Degree of Improvement in Erythematotelangiectatic Rosacea and Papulopustular Rosacea — 2.114; 2.088 score on a scale
Peri-Implantitis
Primary: Change in Periodontal Probing Depths (PD) — 1.85; 2.65 millimeters
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Number of Half Faces to Achieve at Least 25% Improvement in Acne Scarring at Week 24 by Blinded Photo Reviewer — 18; 17 half faces
Scarring · Skin Aging
Primary: Study Effectiveness for Skin Aesthetic Improvement — 1.25 score on a scale
Circumference Reduction
Primary: Change in Combined Circumference Measurements — -5.36 inches — p=<.0001
Temporal Lobe Epilepsy
Primary: Incidence of Qualifying Adverse Events — 7.9 percentage of participants
Rejuvenation
Primary: Degree of Improvement as Assessed by the Investigator (Physician's Global Assessment of Improvement). — 1.7 score on a scale
Autistic Disorder
Primary: Mean Change From Baseline to Study Endpoint in the Aberrant Behavior Checklist (ABC) Irritability & Agitation Subscale Score. — -14.81; 0.37 score on a scale
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Correct Identification of the 12 Weeks Post-final Treatment Photographs From the Baseline Photographs by at Least 2 of the 3 Blinded Reviewers in 75% of the Patients…
Dental Caries
Primary: International Caries Detection and Assessment System (ICDAS II) - Number of Molars With ICDAS Score of 3 or More - ICDAS Score 3, Cavity - — 0; 13 right or left second…
Generalized Moderate Chronic Periodontitis · Generalized Severe Chronic Periodontitis · Periodontal Diseases
Primary: Change in Clinical Attachment Level (CAL) — 3.5; 3.4 mm
Cellulite
Primary: Number of Subjects That Met the Individual Success Criteria — 19; 3 participants — p=<0.0001
Genitourinary System; Disorder, Female · Burning Vagina · Dyspareunia
Primary: Patient Global Impression of Improvement (PGI-I) Score at 4 Weeks After Initial Treatment — 2.66 score on a scale
Scar
Primary: Scar Pain — 1.265; 1.181; 1.048; 1.084 units on a scale — p=0.0492
Tattoo Removal
Primary: Tattoo Clearing as Rated by Blinded Evaluator — 21 Participants
Photoaging
Primary: Change in Aesthetics — 2; 1 score on a scale
Telangiectasis · Spider Veins
Primary: Mean Improvement of Lower Extremity Spider Veins Based on Blinded Photo Assessments — 2.5 points on Improvement scale
Chronic Pain
Primary: Number of Participants Whose Self-reported Degree of Pain on the Visual Analog Scale (VAS) in the Neck and Shoulder Area Decreased by 30% or More From Before to After…
Low Back Pain
Primary: Percentage of Participants Whose Change in Pain Rating on the Visual Analog Scale (VAS) Met the Individual Subject Success Criteria — 21; 8 Participants — p=<0.005
Nephrolithiasis
Primary: Number of Participants With Stone Free Status — 27; 26 Participants
Cognitive Change
Primary: Site-determined Cognitive Changes Per Domain — 49; 50.7; 32.9; 35.3 Score